Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nonthavej Hospital PCLBKK:NTV -0.53%73 ROE % is 6.40% as of Mar. 2026, which is 55% below its 10-year median of 14.34. GuruFocus rates BKK:NTV with a GF Score™ of 73/100 and a GF Value™ of ฿28.88 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 621 Healthcare Providers & Services companies, Nonthavej Hospital PCL ranks better than 59.9% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nonthavej Hospital PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nonthavej Hospital PCL ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nonthavej Hospital PCL's ROE % distribution charts can be found below:
* The bar in red indicates where Nonthavej Hospital PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Nonthavej Hospital PCL (BKK:NTV) has a ROE % of 6.40% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Nonthavej Hospital PCL and its competitors. This is 55% below median its historical median of 14.34. Over the past decade, Nonthavej Hospital PCL's ROE % has ranged from 7.20 to 20.06. According to the industry distribution chart, Nonthavej Hospital PCL ranks #249 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 40.1%.
Is Nonthavej Hospital PCL's ROE % too high?
Nonthavej Hospital PCL's current ROE % of 6.40% is 55% below median its 10-year median of 14.34. Over the past 10 years, this metric has ranged from a low of 7.20 to a high of 20.06. The Healthcare Providers & Services industry median ROE % is 5.88. Nonthavej Hospital PCL's value of 6.40% is 8.8% above this industry median. Based on the distribution chart, Nonthavej Hospital PCL ranks #249 out of 621 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nonthavej Hospital PCL has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nonthavej Hospital PCL's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nonthavej Hospital PCL ranks #249 out of 621 companies for ROE %. This puts Nonthavej Hospital PCL in the upper half of its industry. The industry median ROE % is 5.88. Nonthavej Hospital PCL's value of 6.40% is 8.8% above this benchmark. Historically, Nonthavej Hospital PCL's own ROE % has ranged from 7.20 to 20.06 over the past decade. While the company's 10-year median is 14.34 vs. the industry median of 5.88, Nonthavej Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nonthavej Hospital PCL's current ROE % of 6.40% is 8.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Nonthavej Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nonthavej Hospital PCL's current ROE % is 6.40%, which is 55% below median its own 10-year median of 14.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nonthavej Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Nonthavej Hospital PCL (BKK:NTV) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿28.88, compared to a current price of ฿18.90 — trading 34.6% below its estimated fair value. The current ROE % is 6.40%, which is 55% below median its 10-year median of 14.34 and 8.8% above the Healthcare Providers & Services industry median of 5.88. Nonthavej Hospital PCL's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Nonthavej Hospital PCL (BKK:NTV), the current ROE % is 6.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nonthavej Hospital PCL (BKK:NTV) Overvalued in 2026?
Based on GuruFocus' analysis, Nonthavej Hospital PCL stock appears to be undervalued.
The current stock price of ฿18.90 is trading 34.6% below its estimated GF Value™ of ฿28.88.
GuruFocus considers Nonthavej Hospital PCL to be Significantly Undervalued.
Key valuation signals for BKK:NTV:
ROE %: 6.40% (55% below median its 10-year median of 14.34)
GF Value™: ฿28.88 vs. price of ฿18.90 (34.6% below fair value)
Industry Position: 8.8% above the Healthcare Providers & Services median (#249 of 621)
No single metric tells the full story. See the BKK:NTV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nonthavej Hospital PCL is engaged in the business of medical treatment in Thailand. It provides medical services by specialist physicians in all fields, supported by an experienced medical team. Its facilities include diagnostic and treatment equipment, a wellness center, a mobile digital X-ray unit for on-site and off-site health assessments, and ambulance services for patient transportation. The majority of the company's revenue is derived from hospital operations, which mainly consist of medical fees, hospital room sales, and medicine sales.
73GF Score
Get the complete analysis for BKK:NTV
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NTV has been successfully added to your 
